Chiesi Agrees to Buy KalVista Pharmaceuticals for $1.9 Billion

Chronological Source Flow
Back

AI Fusion Summary

Chiesi announced it will acquire KalVista Pharmaceuticals for $1.9 billion. The deal was announced on a Thursday, and KalVista shares surged 38% on the news, reflecting investor enthusiasm for the acquisition.
29/04 14:05 bloomberg.com
3 Πηγές
29/04 14:42 investing.com
29/04 15:10 investing.com
Comments
Loading...
0